Subscrever
Newsletter

Para subscrever a newsletter preencha os campos

subscrever

Subscrever
Newsletter

Para subscrever a newsletter preencha os campos

Subscribe!

Actually we won’t spam you and keep your personal data secure

 

Call 9 | IMI-2

A Call 9 da IMI-2  foi lançada em abril de 2016 e já terminou. Esta Call teve como intuito financiar propostas para os seguintes tópicos:

  • Addressing the clinical burden of Clostridium difficile infection (CDI): Evaluation of the burden, current practices and set-up of a European research platform (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)
  • Development of immune tolerance therapies for the treatment of rheumatic diseases
  • Data quality in preclinical research and development
  • Next generation of electronic translational safety
  • Identification and validation of biomarkers for non-alcoholic steatohepatitis (NASH) and across the spectrum of non-alcoholic fatty liver disease (NAFLD)
  • Joint influenza vaccine effectiveness studies

Foram submetidas 17 propostas à Call 9 da IMI2, mas apenas 6 foram aprovadas para financiamento.

Publicado: 28 de abril de 2016